Nervosave Therapeutics
PrivateLast Round
Seed
Nov 27, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nervosave Therapeutics is a biotechnology company that develops a gene therapy platform for the treatment of peripheral nerve disorders, including Charcot-Marie-Tooth disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nervosave Therapeutics Comparables
Compare Nervosave Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Armatus Bio | 82% | |
| Novartis | 69% | |
| Augustine Therapeutics | 67% | |
Nervosave Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 27, 2025 |
Nervosave Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SATT AxLR | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 27, 2025
Seed round led by SATT AxLR.
- Oct 29, 2024
Monthly visitors increased 37% MoM, from 491 to 671.
Nervosave Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nervosave Therapeutics's valuation, stock price, and market status.